Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Merck
Deloitte
Chubb
Federal Trade Commission
Cantor Fitzgerald
Chinese Patent Office
Cerilliant

Generated: June 23, 2018

DrugPatentWatch Database Preview

PREDSULFAIR Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Predsulfair, and when can generic versions of Predsulfair launch?

Predsulfair is a drug marketed by Pharmafair and is included in three NDAs.

The generic ingredient in PREDSULFAIR is prednisolone acetate; sulfacetamide sodium. There are eighty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.
Summary for PREDSULFAIR
US Patents:0
Applicants:1
NDAs:3
Formulation / Manufacturing:see details
DailyMed Link:PREDSULFAIR at DailyMed
Drug patent expirations by year for PREDSULFAIR

US Patents and Regulatory Information for PREDSULFAIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair PREDSULFAIR prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 088032-001 Apr 15, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmafair PREDSULFAIR prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088007-001 Apr 19, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmafair PREDSULFAIR II prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088837-001 Dec 24, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
US Department of Justice
Medtronic
Harvard Business School
AstraZeneca
Fuji
Argus Health
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.